Is mesalazine enema covered by medical insurance reimbursement?

Legal analysis: mesalazine is a medical insurance drug and can be reimbursed. In fact, due to China's unbalanced economic development and different levels of medical insurance financing, in order to ensure the basic medical drugs for the insured, the basic medical insurance drug list is divided into Class A and Class B. The expenses of drugs listed in Class A shall be paid by the basic medical insurance fund according to regulations, and guaranteed payment shall be implemented in all overall planning areas of the country.

Legal basis: Article 59 of the Law of People's Republic of China (PRC) on Basic Medical Care and Health Promotion, the state implements the system of essential drugs, and selects an appropriate number of essential drugs to meet the demand for essential drugs for disease prevention and treatment. The state publishes the list of essential drugs, and adjusts the list of essential drugs according to the clinical application practice of drugs, changes in drug standards and the dynamics of newly listed drugs. Essential drugs are given priority in the list of basic medical insurance drugs according to regulations. The state improves the supply capacity of essential drugs, strengthens the quality supervision of essential drugs, and ensures the fair, accessible and rational use of essential drugs.